Impact of monthly prescription cap on medication persistence among patients with hypertension, hyperlipidemia, or diabetes
Journal
Journal of managed care pharmacy : JMCP
Journal Volume
19
Journal Issue
3
Pages
258
Date Issued
2013-04
Author(s)
Abstract
Hypertension, hyperlipidemia, and diabetes are among the most prevalent and costly chronic health conditions affecting the U.S. population. Prescription treatments for these conditions are of critical importance to the health of patients, yet suboptimal adherence to prescription treatments for these conditions is not uncommon. While monthly prescription restriction has become a commonly used mechanism to reduce medication utilization, little is known about the effect of this policy on patients with hypertension, hyperlipidemia, or diabetes.
SDGs
Type
journal article